Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
(2S)-4-(2,5-difluorophenyl)-N,N-dimethyl-2-phenyl-2,5-dihydro-1H-pyrrole-1-carboxamide is a synthetic small molecule belonging to the pyrrole carboxamide class. It has a molecular formula of C19H18F2N2O and a molecular weight of approximately 328.36 g/mol[1][6][8]. The compound is listed as an experimental drug candidate and does not have any approved medical indications or known clinical use as of now[2][9]. Its mechanism of action and pharmacological targets are not described in public databases or literature. The compound appears in chemical libraries and structural databases for research purposes but lacks information on biological activity or therapeutic application[3][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on (2S)-4-(2,5-difluorophenyl)-N,N-dimethyl-2-phenyl-2,5-dihydro-1H-pyrrole-1-carboxamide.